European Alliance for Responsible R&D and Affordable Medicines
  • Medicines Prices 2017
Select Page
Alliance’s response to the European Commission’s consultation on Compulsory Licensing

Alliance’s response to the European Commission’s consultation on Compulsory Licensing

by European Alliance | May 23, 2022 | News

The European Alliance for Responsible R&D and Affordable Medicines welcomed the opportunity to provide feedback within this European Commission’s consultation on Intellectual property: revised framework for compulsory licensing of patents. Compulsory...
The prevention of medicine shortages in the EU: a key priority of the pharmaceutical legislation revision process

The prevention of medicine shortages in the EU: a key priority of the pharmaceutical legislation revision process

by European Alliance | Apr 7, 2022 | News

The Members of the European Alliance for Responsible R&D and Affordable Medicines have published a note today outlining key recommendations to prevent and mitigate shortages of medicines in the upcoming revision of the pharmaceutical legislation.   The note...
Call to protect the health of people affected by the war in Ukraine

Call to protect the health of people affected by the war in Ukraine

by European Alliance | Mar 14, 2022 | News

The European Alliance for Responsible R&D and Affordable Medicines calls for all parties to protect the health and welfare and guarantee access to medical tools and healthcare for all people affected by the ongoing war in Ukraine Members of the Alliance are deeply...
Transparency of (real) pharmaceutical costs webinar: 18 January

Transparency of (real) pharmaceutical costs webinar: 18 January

by European Alliance | Jan 13, 2022 | News

On Tuesday 18 January 2022 (14:00-15:15), the Alliance co-hosted the second event of the Zooming in on Solution to the Affordability of Medicines webinar series along with Global Health Advocates (GHA) and the European Public Health Alliance (EPHA). Speakers and...
Getting incentives right in the new EU pharmaceutical strategy

Getting incentives right in the new EU pharmaceutical strategy

by European Alliance | Dec 21, 2021 | News

Brussels, 21 December 2021 Members of the Alliance have published a note today outlining key recommendations of civil society organisations for the new EU pharmaceutical strategy. A key pillar for this new strategy is the balance between providing innovation...
Regional dialogue for EU activists (GSIPA2M-2021Virtual): 17 November

Regional dialogue for EU activists (GSIPA2M-2021Virtual): 17 November

by European Alliance | Nov 15, 2021 | News

On Wednesday 17 November (9:30-11:30 am), the Alliance organized the regional dialogue for EU activists working on overcoming patent and other intellectual property barriers to access to health technologies. The dialogue provided a place for EU activists to reflect on...
« Older Entries
  • Facebook
  • Twitter
  • Google
  • RSS

Designed by Elegant Themes | Powered by WordPress